CryoLife rises after announcing legal settlements – MSN Money

"CryoLife is now free of its multi-year entanglement with Medafor and we are aware of no other significant legal issues to distract management from executing its growth plan," he wrote. Myers maintained a "buy" rating and price target of $7.50 ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*


*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>